Investing in STA start-ups
Learn about the opportunity to co-invest in STA start-ups
Start-up deal: BioMensio
Learn how STA successfully commercialized bio-sensor technology via startup BioMensio
Read what our co-investors, start-up founders
and licensing partners say about STA.
Investing in STA start-ups
Adding genuine value for venture capital funds, and institutional and private investors
Siemens Technology Accelerator (STA) offers attractive investment opportunities in the start-up companies we found for venture capital funds and institutional and private investors, adding value through our industry, and technology know-how and access to Siemens’ global resources.
Access to high-value technologies
STA commercializes innovative Siemens technologies that have been developed by the company’s global research and development network. Investors in these technologies gain access to market opportunities outside of Siemens core business that STA has evaluated to ensure they hold the potential for high business value, while thoroughly analyzing both technology and market risks. And every STA technology is well protected by patents.
Single point of contact
STA simplifies the commercialization process as much as possible for investors by serving as their single point of contact within Siemens. STA addresses all technological, legal and financial areas of the start-up formation process, reducing the complexities that come with working with a large, multinational company. STA also ensures the smooth transfer of the technology and operational know-how to the start-up.
Co-investing with STA
STA provides the start-up companies it founds with both know-how and early stage financing to help accelerate its initial development. STA continues to drive both the value and viability of the start-ups by becoming a shareholder, and continuing to co-invest in future fundraising rounds. Since the newly created businesses are outside of Siemens core business, STA looks to co-finance its start-ups with external funding sources, including venture capital funds, private investors and corporate and strategic investors.
STA’s track record of success in founding venture capital financed start-ups ensures that these investments are in companies that have been established on a sound foundation and are ready for investment. STA has extensive experience recruiting complete, expert management teams with entrepreneurial experience for start-ups. In some cases, experienced Siemens staff members that have been involved in the development of the technology at Siemens leave the company and join the start-up.
Access to Siemens’ Network
Most start-ups face a significant challenge in finding and acquiring new customers. STA-founded start-ups have access to the Siemens’ global network, and its large existing customer base. STA identifies potential lead customers, and works closely with them throughout the commercialization process. Often, STA start-ups land development or manufacturing partnerships with Siemens, further increasing their investment value.
The commercialization process
Technology: Bio Sensors
Siemens Corporate Technology has developed a patented piezo-electric bio-sensor based on a unique sputtering thin film technology. The sensor allows implementation of hand-held devices for parallel screening of biological samples for different target molecules. The sensor can be easily customized to support a variety of applications like drugs-of-abuse or food-safety testing.
External commercialization drivers: Why external?
Siemens AG had previously spun off its component businesses, divesting its semiconductor business to Infineon and its passive electrical components businesses to EPCOS, among others. As a result, there wasn’t a strategic fit for the technology within Siemens businesses.
External commercialization strategy: Why start-ups vs. sale?
Siemens Corporate Technology has previously spun off its component businesses, divesting among others its passive electrical components business to EPCOS. As a result, there was no longer a strategic fit for a bio-sensor component within Siemens. In addition, the most promising application opportunities for the bio-sensor were found to be outside of Siemens‘ business fields.
Start-ups founding and financing with venture capital:
BioMensio took up operations in August 2016 in Tampere, Finland. There were mainly three reasons to place the start-up in Finland:
- The readout electronics for the bio-sensor had been developed by VTT Research Center of Finland and VTT’s venture arm, VTT Ventures, agreed to co-finance the startup.
- A group of Finnish angle investors also agreed to co-finance the startup. The lead investor from this group already had experience in bio-sensing startups.
- TEKES, the Finnish funding agency for technology startups, agreed to provide substantial financial support for the startup.
In total, the group of investors and TEKES raised 2.5 Mio. EUR for the seed round of BioMensio.
Current business status:
As of 2017, BioMensio has developed a near-commercial desktop bio-sensing system which serves as basis for developing bio-applications (so-called BioApps) for the handheld platform. Discussions are ongoing with third parties to develop BioApps for the system.
The bio-sensor as such has also been evolved for enhanced sensitivity and manufacturability. By the end of 2017, BioMensio is also planning to make available a first version of a portable system.
Read what our
co-investors, start-up founders
and licensing partners say about their experiences working with STA.